[1]
|
Taioufis, C., Thornopoulos, K., Dimitriadis, K., Anastasia, A., Dimitris, T., Christodoulos, S., et al. (2007) The Incremental Effect of Obstructive Sleep Apnoea Syndrome on Arterial Stiffness in Newly Diagnosed Essential Hypertensive Subjects. Journal of Hypertension, 26, 141-146. https://doi.org/10.1097/HJH.0b013e32801092c1
|
[2]
|
Bhushan, B., Guleria, R., Misra, A., Pandey, R.M., Luthra, K., Vikram, N.K., et al. (2009) Obstructive Sleep Apnoea Correlates with C-Reactive Protein in Obese Asian Indians. Nutrition, Metabolism and Cardiovascular Diseases, 19, 184-189. https://doi.org/10.1016/j.numecd.2008.06.008
|
[3]
|
Collison, L.W., Workman, C.J., Kuo, T.T., Boyd, K., Wang, Y., Vignali, K.M., et al. (2007) The Inhibitory Cytokine IL-35 Contributes to Regulatory T-Cell Function. Nature, 450, 566-569. https://doi.org/10.1038/nature06306
|
[4]
|
Chaturvedi, V., Collison, L.W., Guy, C.S., Workman, C.J. and Vignali, D.A.A. (2011) Cutting Edge: Human Regulatory T Cells Require IL-35 to Mediate Suppression and Infectious Tolerance. Journal of Immunology, 186, 6661-6666.
https://doi.org/10.4049/jimmunol.1100315
|
[5]
|
Li, X., Mai, J., Virtue, A., Yin, Y., Gong, R., Sha, X., et al. (2012) IL-35 Is a Novel Responsive Anti-Inflammatory Cytokine—A New System of Categorizing Anti-Inflammatory Cytokines. PLoS ONE, 7, e33628.
https://doi.org/10.1371/journal.pone.0033628
|
[6]
|
Lee, Y.K. and Mazmanian, S.K. (2010) Has the Microbiota Played a Critical Role in the Evolution of the Adaptive Immune System? Science, 330, 1768-1773. https://doi.org/10.1126/science.1195568
|
[7]
|
Chen, P. and Fang, S. (2004) The Expression of Human Antimicrobial Peptide LL-37 in the Human Nasal Mucosa. The American Journal of Rhinology, 18, 381-385. https://doi.org/10.1177/194589240401800608
|
[8]
|
Guilleminault, C., Tilkian, A. and Dement, W.C. (1976) The Sleep Apnea Syndromes. Annual Review of Medicine, 27, 465-484. https://doi.org/10.1146/annurev.me.27.020176.002341
|
[9]
|
Marcus, C.L., Brooks, L.J., Draper, K.A., Gozal, D., Halbower, A.C., Jones, J., et al. (2012) Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome, Pediatrics, 130, 576-584.
https://doi.org/10.1542/peds.2012-1671
|
[10]
|
中华医学会呼吸病学分会睡眠呼吸障碍学组. 阻塞性睡眠呼吸暂停低通气合征诊治指南(2011年修订版)[J].中华结核和呼吸杂志, 2012, 35(1): 9-12.
|
[11]
|
De Luca Canto, G., Pacheco-Pereira, C., Aydinoz, S., Major, P.W., Flores Mir, C. and Gozal, D. (2014) Biomarkers Associated with Obstructive Sleep Apnea: A Scoping Review. Sleep Medicine Reviews, 23, 28-45.
https://doi.org/10.1016/j.smrv.2014.11.004
|
[12]
|
Katz, E.S. and D’Ambrosio, C.M. (2010) Pediatric Obstructive Sleep Apnea Syndrome. Clinics in Chest Medicine, 31, 221-234. https://doi.org/10.1016/j.ccm.2010.02.002
|
[13]
|
Farber, J.M. (2002) Clinical Practice Guideline: Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome. Pediatrics, 110, 1255-1257. https://doi.org/10.1542/peds.110.6.1255-a
|
[14]
|
Ryan, S., Taylor, C.T. and McNicholas, W.T. (2009) Systemic Inflammation: A Key Factor in the Pathogenesis of Cardiovascular Complications in Obstructive Sleep Apnoea Syndrome. Thorax, 64, 631-636.
|
[15]
|
Minoguchi, K., Tazaki, T., Yokoe, T., Minoguchi, H., Watanabe, Y., Yamamoto, M., et al. (2004) Elevated Production of Tumor Necrosis Factor-Alpha by Monocytes in Patients with Obstructive Sleep Apnea Syndrome. Chest, 126, 1473-1479. https://doi.org/10.1378/chest.126.5.1473
|
[16]
|
Lui, M.M., Lam, J.C., Mak, H.K., Xu, A., Ooi, C., Lam, D.C., et al. (2009) C-Reactive Protein Is Associated with Obstructive Sleep Apnea Independent of Visceral Obesity. Chest, 135, 950-956. https://doi.org/10.1378/chest.08-1798
|
[17]
|
Mehra, R., Storfer-Isser, A., Kirchner, H.L., Johnson, N., Jenny, N., Tracy, R.P., et al. (2006) Soluble Interleukin 6 Receptor: A Novel Marker of Moderate to Severe Sleep-Related Breathing Disorder. Archives of Internal Medicine, 166, 1725-1731. https://doi.org/10.1001/archinte.166.16.1725
|
[18]
|
Nural, S., Gunay, E., Halici, B., Celik, S. and Unlu, M. (2013) Inflammatory Processes and Effects of Continuous Positive Airway Pressure (CPAP) in Overlap Syndrome. Inflammation, 36, 66-74.
https://doi.org/10.1007/s10753-012-9520-z
|
[19]
|
Svensson, M., Venge, P., Janson, C. and Lindberg, E. (2012) Relationship between Sleep-Disordered Breathing and Markers of Systemic Inflammation in Women from the General Population. Journal of Sleep Research, 21, 147-154.
https://doi.org/10.1111/j.1365-2869.2011.00946.x
|
[20]
|
Yokoe, T., Minoguchi, K., Matsuo, H., Oda, N., Minoguchi, H., Yoshino, G., et al. (2003) Elevated Levels of C-Reactive Protein Andinterleukin-6 in Patients with Obstructive Sleep Apnea Syndrome Are Decreased by Nasal Continuous Positive Airway Pressure. Circulation, 107, 1129-1134.
https://doi.org/10.1161/01.CIR.0000052627.99976.18
|
[21]
|
Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., Kales, A., Tyson, K. and Chrousos, G.P. (1997) Elevation of Plasma Cytokines in Disorders of Excessive Daytime Sleepiness: Role of Sleep Disturbance and Obesity. The Journal of Clinical Endocrinology and Metabolism, 82, 1313-1316. https://doi.org/10.1210/jcem.82.5.3950
|
[22]
|
Zandian, M., Mott, K.R., Allen, S.J., Dumitrascu, O., Kuo, J.Z. and Ghiasi, H. (2011) Use of Cytokine Immunotherapy to Block CNS Demyelination Induced by a Recombinant HSV-1 Expressing IL-2. Gene Therapy, 18, 734-742.
https://doi.org/10.1038/gt.2011.32
|
[23]
|
Kochetkova, I., Golden, S., Holderness, K., Callis, G. and Pascual, D.W. (2010) IL-35 Stimulation of CD39+ Regulatory T Cells Confers Protection against Collagen II-Induced Arthritis via the Production of IL-10. Journal of Immunology, 184, 7144-7153. https://doi.org/10.4049/jimmunol.0902739
|
[24]
|
Whitehead, G.S., Wilson, R.H., Nakano, K., Burch, L.H., Nakano, H. and Cook, D.N. (2012) IL-35 Production by Inducible Costimulator (ICOS)-Positive Regulatory T Cells Reverses Established IL-17-Dependent Allergic Airways Disease. Journal of Allergy and Clinical Immunology, 129, 207-215.E5. https://doi.org/10.1016/j.jaci.2011.08.009
|
[25]
|
Wirtz, S., Billmeier, U., McHedlidze, T., Blumberg, R.S. and Neurath, M.F. (2011) Interleukin-35 Mediates Mucosal Immune Responses That Protect against T-Cell-Dependent Colitis. Gastroenterology, 141, 1875-1886.
https://doi.org/10.1053/j.gastro.2011.07.040
|
[26]
|
Devergne, O., Birkenbach, M. and Kieff, E. (1997) Epstein-Barr Virus-Induced Gene 3 and the p35 Subunit of Interleukin 12 form a Novel Heterodimeric Hematopoietin. Proceedings of the National Academy of Sciences of the United States of America, 94, 12041-12046. https://doi.org/10.1073/pnas.94.22.12041
|
[27]
|
Yang, J., Yang, M., Htut, T.M., Ouyang, X., Hanidu, A., Li, X., et al. (2008) Epstein-Barr Virus-Induced Gene 3 Negatively Regulates IL-17, IL-22 and ROR𝛾t. European Journal of Immunology, 38, 1204-1214.
https://doi.org/10.1002/eji.200838145
|
[28]
|
Frank, G.M., Divito, S.J., Maker, D.M., Xu, M. and Hendricks, R.L. (2010) A Novel P40-Independent Function of IL-12P35 Is Required for Progression and Maintenance of Herpes Stromal Keratitis. Investigative Ophthalmology and Visual Science, 51, 3591-3598. https://doi.org/10.1167/iovs.09-4368
|
[29]
|
Ye, S., Wu, J., Zhou, L., Lv, Z., Xie, H. and Zheng, S. (2013) Interleukin-35: The Future of Hyperimmune-Related Diseases? Journal of Interferon and Cytokine Research, 33, 285-291. https://doi.org/10.1089/jir.2012.0086
|
[30]
|
Collison, L.W., Delgoffe, G.M., Guy, C.S., Vignali, K.M., Chaturvedi, V., Fairweather, D.L., et al. (2012) The Composition and Signaling of the IL-35 Receptor Are Unconventional. Nature Immunology, 13, 290-299.
https://doi.org/10.1038/ni.2227
|
[31]
|
Nold, M.F., Nold-Petry, C.A., Zepp, J.A., Palmer, B.E., Bufler, P. and Dinarello, C.A. (2010) IL-37 Is a Fundamental Inhibitor of Innate Immunity. Nature Immunology, 11, 1014-1022. https://doi.org/10.1038/ni.1944
|
[32]
|
Boraschi, D., Lucchesi, D., Hainzl, S., Leitner, M., Maier, E., Mangelberger, D., et al. (2011) IL-37: A New Anti-Inflammatory Cytokine of the IL-1 Family. European Cytokine Network, 22, 127-147.
https://www.jle.com/10.1684/ecn.2011.0288
|
[33]
|
de Smet, K. and Contreras, R. (2005) Human Antimicrobial Peptides: Defensins, Cathelicidins and Histatins. Biotechnology Letters, 27, 1337-1347. https://doi.org/10.1007/s10529-005-0936-5
|